Clinical review report Preservative-free latanoprost 50 [m]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Lowering intraocular pressure (IOP) is the only clinically established method of treating glaucoma, and the Canadian Ophthalmological Society's clinical practice guidelines for glaucoma recommend an initial target IOP based on the severity of glaucoma, to be modified based on patients' age...

Descripción completa

Detalles Bibliográficos
Autor principal: Canadian Agency for Drugs and Technologies in Health (author)
Autor Corporativo: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health 2018.
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820282206719

Ejemplares similares